Literature DB >> 1582685

Neurocysticercosis--a review of 231 cases.

L Monteiro1, T Coelho, A Stocker.   

Abstract

Two hundred thirty-one cases of neurocysticercosis are reviewed. Diagnosis was established by cerebral computed tomography during a seven-year period (1983-1989). One hundred and fourty-four (62%) presented with symptom-related disease (symptomatic neurocysticercosis and in 87 the diagnosis was incidental (asymptomatic neurocysticercosis). In symptomatic neurocysticercosis the parasitosis was considered inactive in 115 cases and active in 29. Seizures occurred in 135 patients (96% of the symptomatic neurocysticercosis). In the active form we also found: meningitis (n = 15), intracranial hypertension (n = 12), hydrocephalus (n = 10) and arteritis (n = 2). Treatment included praziquantel (n = 21), albendazole (n = 4), dexamethasone (n = 18) and surgery (n = 10).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582685     DOI: 10.1007/bf01711064

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  34 in total

1.  Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

Authors:  J Sotelo; O H del Brutto; P Penagos; F Escobedo; B Torres; J Rodriguez-Carbajal; F Rubio-Donnadieu
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

2.  MR imaging in neurocysticercosis: a study of 56 cases.

Authors:  H R Martinez; R Rangel-Guerra; G Elizondo; J Gonzalez; L E Todd; J Ancer; S S Prakash
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

3.  Use of enzyme-linked immunosorbent assay in the diagnosis of cysticercosis.

Authors:  G Ramírez; G Pradilla
Journal:  Arch Neurol       Date:  1987-09

4.  The relationship of antibody levels to the clinical spectrum of human neurocysticercosis.

Authors:  D Zini; V J Farrell; A A Wadee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

5.  Therapy of parenchymal brain cysticercosis with praziquantel.

Authors:  J Sotelo; F Escobedo; J Rodriguez-Carbajal; B Torres; F Rubio-Donnadieu
Journal:  N Engl J Med       Date:  1984-04-19       Impact factor: 91.245

6.  A prognostic classification of cerebral cysticercosis: therapeutic implications.

Authors:  B Estañol; T Corona; P Abad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

7.  Cysticercosis cerebri. Review of 127 cases.

Authors:  G F McCormick; C S Zee; J Heiden
Journal:  Arch Neurol       Date:  1982-09

8.  Carotid occlusion in cysticercosis.

Authors:  G F McCormick; S Giannotta; C Zee; M Fisher
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

9.  Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations.

Authors:  M J Chandy; V Rajshekhar; S Ghosh; S Prakash; T Joseph; J Abraham; S M Chandi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

10.  Albendazole therapy for neurocysticercosis.

Authors:  F Escobedo; P Penagos; J Rodriguez; J Sotelo
Journal:  Arch Intern Med       Date:  1987-04
View more
  8 in total

1.  Magnitude of the disease burden from neurocysticercosis in a developing country.

Authors:  C Bern; H H Garcia; C Evans; A E Gonzalez; M Verastegui; V C Tsang; R H Gilman
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

Review 2.  Treatment strategies after a single seizure : rationale for immediate versus deferred treatment.

Authors:  Laura C Miller; Frank W Drislane
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Multilevel intramedullary spinal neurocysticercosis with eosinophilic meningitis.

Authors:  Amir M Torabi; Mary Quiceno; Dianne B Mendelsohn; Craig M Powell
Journal:  Arch Neurol       Date:  2004-05

Review 4.  Calcific neurocysticercosis and epileptogenesis.

Authors:  T E Nash; O H Del Brutto; J A Butman; T Corona; A Delgado-Escueta; R M Duron; C A W Evans; R H Gilman; A E Gonzalez; J A Loeb; M T Medina; S Pietsch-Escueta; E J Pretell; O M Takayanagui; W Theodore; V C W Tsang; H H Garcia
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

Review 5.  Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011.

Authors:  Lorenzo Zammarchi; Marianne Strohmeyer; Filippo Bartalesi; Elisa Bruno; José Muñoz; Dora Buonfrate; Alessandra Nicoletti; Héctor Hugo García; Edoardo Pozio; Alessandro Bartoloni
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

Review 6.  Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients.

Authors:  L Monteiro; J Almeida-Pinto; A Stocker; M Sampaio-Silva
Journal:  J Neurol       Date:  1993-11       Impact factor: 4.849

7.  Influence of gender on cardiac and encephalic inflammation in the elderly with cysticercosis: a case control study.

Authors:  Camila Lourencini Cavellani; Rosana Rosa Miranda Corrêa; Mara Lúcia Fonseca Ferraz; Laura Penna Rocha; Ana Carolina Guimarães Faleiros; Ruy de Souza Lino Junior; Marlene Antônia Dos Reis; Vicente de Paula Antunes Teixeira
Journal:  J Trop Med       Date:  2012-09-26

Review 8.  Clinical manifestations associated with neurocysticercosis: a systematic review.

Authors:  Hélène Carabin; Patrick Cyaga Ndimubanzi; Christine M Budke; Hai Nguyen; Yingjun Qian; Linda Demetry Cowan; Julie Ann Stoner; Elizabeth Rainwater; Mary Dickey
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.